Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Cellular reprogramming for successful CNS axon regeneration is driven by a temporally changing cast of transcription factors.

Dhara SP, Rau A, Flister MJ, Recka NM, Laiosa MD, Auer PL, Udvadia AJ.

Sci Rep. 2019 Oct 2;9(1):14198. doi: 10.1038/s41598-019-50485-6.

2.

Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells.

Nanbakhsh A, Srinivasamani A, Holzhauer S, Riese MJ, Zheng Y, Wang D, Burns R, Reimer MH, Rao S, Lemke A, Tsaih SW, Flister MJ, Lao S, Dahl R, Thakar MS, Malarkannan S.

Cancer Immunol Res. 2019 Oct;7(10):1647-1662. doi: 10.1158/2326-6066.CIR-18-0934. Epub 2019 Sep 12.

PMID:
31515257
3.

Mapping Mammary Tumor Traits in the Rat.

Flister MJ, Joshi A, Bergom C, Rui H.

Methods Mol Biol. 2019;2018:249-267. doi: 10.1007/978-1-4939-9581-3_12.

PMID:
31228161
4.

The p52 isoform of SHC1 is a key driver of breast cancer initiation.

Wright KD, Miller BS, El-Meanawy S, Tsaih SW, Banerjee A, Geurts AM, Sheinin Y, Sun Y, Kalyanaraman B, Rui H, Flister MJ, Sorokin A.

Breast Cancer Res. 2019 Jun 15;21(1):74. doi: 10.1186/s13058-019-1155-7.

5.

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.

Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4.

PMID:
31165373
6.

Mitochondrial Oxidative Phosphorylation defect in the Heart of Subjects with Coronary Artery Disease.

Ait-Aissa K, Blaszak SC, Beutner G, Tsaih SW, Morgan G, Santos JH, Flister MJ, Joyce DL, Camara AKS, Gutterman DD, Donato AJ, Porter GA Jr, Beyer AM.

Sci Rep. 2019 May 20;9(1):7623. doi: 10.1038/s41598-019-43761-y.

7.

Identification of a Rat Mammary Tumor Risk Locus That Is Syntenic with the Commonly Amplified 8q12.1 and 8q22.1 Regions in Human Breast Cancer Patients.

Plasterer C, Tsaih SW, Lemke A, Schilling R, Dwinell M, Rau A, Auer P, Rui H, Flister MJ.

G3 (Bethesda). 2019 May 7;9(5):1739-1743. doi: 10.1534/g3.118.200873.

8.

Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3.

Schlaak RA, Frei A, Schottstaedt AM, Tsaih SW, Fish BL, Harmann L, Liu Q, Gasperetti T, Medhora M, North PE, Strande JL, Sun Y, Rui H, Flister MJ, Bergom C.

Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1267-H1280. doi: 10.1152/ajpheart.00482.2018. Epub 2019 Mar 8.

PMID:
30848680
9.

Genetic variations in human papillomavirus and cervical cancer outcomes.

Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ.

Int J Cancer. 2019 May 1;144(9):2206-2214. doi: 10.1002/ijc.32038. Epub 2019 Jan 4.

PMID:
30515767
10.

IL-13 promotes in vivo neonatal cardiomyocyte cell cycle activity and heart regeneration.

Wodsedalek DJ, Paddock SJ, Wan TC, Auchampach JA, Kenarsary A, Tsaih SW, Flister MJ, O'Meara CC.

Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H24-H34. doi: 10.1152/ajpheart.00521.2018. Epub 2018 Oct 19.

PMID:
30339498
11.

Erratum: Methods for detecting host genetic modifiers of tumor vascular function using dynamic near-infrared fluorescence imaging: errata.

Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A.

Biomed Opt Express. 2018 May 7;9(6):2543. doi: 10.1364/BOE.9.002543. eCollection 2018 Jun 1.

12.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
13.

Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods.

Parchur AK, Sharma G, Jagtap JM, Gogineni VR, LaViolette PS, Flister MJ, White SB, Joshi A.

ACS Nano. 2018 Jul 24;12(7):6597-6611. doi: 10.1021/acsnano.8b01424. Epub 2018 Jul 6.

PMID:
29969226
14.

Genetic Modifiers of the Breast Tumor Microenvironment.

Flister MJ, Bergom C.

Trends Cancer. 2018 Jun;4(6):429-444. doi: 10.1016/j.trecan.2018.04.003. Epub 2018 May 8. Review.

15.

mTORC1 and mTORC2 differentially promote natural killer cell development.

Yang C, Tsaih SW, Lemke A, Flister MJ, Thakar MS, Malarkannan S.

Elife. 2018 May 29;7. pii: e35619. doi: 10.7554/eLife.35619.

16.

A High-Resolution Genetic Map for the Laboratory Rat.

Littrell J, Tsaih SW, Baud A, Rastas P, Solberg-Woods L, Flister MJ.

G3 (Bethesda). 2018 Jul 2;8(7):2241-2248. doi: 10.1534/g3.118.200187.

17.

Methods for detecting host genetic modifiers of tumor vascular function using dynamic near-infrared fluorescence imaging.

Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A.

Biomed Opt Express. 2018 Jan 9;9(2):543-556. doi: 10.1364/BOE.9.000543. eCollection 2018 Feb 1. Erratum in: Biomed Opt Express. 2018 May 07;9(6):2543.

18.

Characterization of Coding/Noncoding Variants for SHROOM3 in Patients with CKD.

Prokop JW, Yeo NC, Ottmann C, Chhetri SB, Florus KL, Ross EJ, Sosonkina N, Link BA, Freedman BI, Coppola CJ, McDermott-Roe C, Leysen S, Milroy LG, Meijer FA, Geurts AM, Rauscher FJ 3rd, Ramaker R, Flister MJ, Jacob HJ, Mendenhall EM, Lazar J.

J Am Soc Nephrol. 2018 May;29(5):1525-1535. doi: 10.1681/ASN.2017080856. Epub 2018 Feb 23.

19.

Genetic Fine-Mapping and Identification of Candidate Genes and Variants for Adiposity Traits in Outbred Rats.

Keele GR, Prokop JW, He H, Holl K, Littrell J, Deal A, Francic S, Cui L, Gatti DM, Broman KW, Tschannen M, Tsaih SW, Zagloul M, Kim Y, Baur B, Fox J, Robinson M, Levy S, Flister MJ, Mott R, Valdar W, Solberg Woods LC.

Obesity (Silver Spring). 2018 Jan;26(1):213-222. doi: 10.1002/oby.22075. Epub 2017 Nov 28.

20.

SmgGDS is a transient nucleolar protein that protects cells from nucleolar stress and promotes the cell cycle by regulating DREAM complex gene expression.

Gonyo P, Bergom C, Brandt AC, Tsaih SW, Sun Y, Bigley TM, Lorimer EL, Terhune SS, Rui H, Flister MJ, Long RM, Williams CL.

Oncogene. 2017 Dec 14;36(50):6873-6883. doi: 10.1038/onc.2017.280. Epub 2017 Aug 14.

21.

Host genetic modifiers of nonproductive angiogenesis inhibit breast cancer.

Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A.

Breast Cancer Res Treat. 2017 Aug;165(1):53-64. doi: 10.1007/s10549-017-4311-8. Epub 2017 May 31.

22.

MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.

Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z.

PLoS One. 2015 May 4;10(5):e0125412. doi: 10.1371/journal.pone.0125412. eCollection 2015.

23.

2015 Guidelines for Establishing Genetically Modified Rat Models for Cardiovascular Research.

Flister MJ, Prokop JW, Lazar J, Shimoyama M, Dwinell M, Geurts A; International Committee on Standardized Genetic Nomenclature for Mice; Rat Genome and Nomenclature Committee.

J Cardiovasc Transl Res. 2015 Jun;8(4):269-77. doi: 10.1007/s12265-015-9626-4. Epub 2015 Apr 29. Review.

24.

SH2B3 Is a Genetic Determinant of Cardiac Inflammation and Fibrosis.

Flister MJ, Hoffman MJ, Lemke A, Prisco SZ, Rudemiller N, O'Meara CC, Tsaih SW, Moreno C, Geurts AM, Lazar J, Adhikari N, Hall JL, Jacob HJ.

Circ Cardiovasc Genet. 2015 Apr;8(2):294-304. doi: 10.1161/CIRCGENETICS.114.000527. Epub 2015 Jan 27.

PMID:
25628389
25.

Vascular dysfunction precedes hypertension associated with a blood pressure locus on rat chromosome 12.

Prisco SZ, Priestley JR, Weinberg BD, Prisco AR, Hoffman MJ, Jacob HJ, Flister MJ, Lombard JH, Lazar J.

Am J Physiol Heart Circ Physiol. 2014 Oct 15;307(8):H1103-10. doi: 10.1152/ajpheart.00464.2014. Epub 2014 Aug 22.

26.

Shroom3 contributes to the maintenance of the glomerular filtration barrier integrity.

Yeo NC, O'Meara CC, Bonomo JA, Veth KN, Tomar R, Flister MJ, Drummond IA, Bowden DW, Freedman BI, Lazar J, Link BA, Jacob HJ.

Genome Res. 2015 Jan;25(1):57-65. doi: 10.1101/gr.182881.114. Epub 2014 Oct 1.

27.

CXM: a new tool for mapping breast cancer risk in the tumor microenvironment.

Flister MJ, Endres BT, Rudemiller N, Sarkis AB, Santarriaga S, Roy I, Lemke A, Geurts AM, Moreno C, Ran S, Tsaih SW, De Pons J, Carlson DF, Tan W, Fahrenkrug SC, Lazarova Z, Lazar J, North PE, LaViolette PS, Dwinell MB, Shull JD, Jacob HJ.

Cancer Res. 2014 Nov 15;74(22):6419-29. doi: 10.1158/0008-5472.CAN-13-3212. Epub 2014 Aug 29.

28.

Mutation of Plekha7 attenuates salt-sensitive hypertension in the rat.

Endres BT, Priestley JR, Palygin O, Flister MJ, Hoffman MJ, Weinberg BD, Grzybowski M, Lombard JH, Staruschenko A, Moreno C, Jacob HJ, Geurts AM.

Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12817-22. doi: 10.1073/pnas.1410745111. Epub 2014 Aug 18.

29.

Refined mapping of a hypertension susceptibility locus on rat chromosome 12.

Prisco SZ, Prokop JW, Sarkis AB, Yeo NC, Hoffman MJ, Hansen CC, Jacob HJ, Flister MJ, Lazar J.

Hypertension. 2014 Oct;64(4):883-90. doi: 10.1161/HYPERTENSIONAHA.114.03550. Epub 2014 Jul 7.

30.

Identifying multiple causative genes at a single GWAS locus.

Flister MJ, Tsaih SW, O'Meara CC, Endres B, Hoffman MJ, Geurts AM, Dwinell MR, Lazar J, Jacob HJ, Moreno C.

Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4.

31.

Female-specific hypertension loci on rat chromosome 13.

Hoffman MJ, Flister MJ, Nunez L, Xiao B, Greene AS, Jacob HJ, Moreno C.

Hypertension. 2013 Sep;62(3):557-63. doi: 10.1161/HYPERTENSIONAHA.113.01708. Epub 2013 Jul 1.

32.

Congenic mapping and sequence analysis of the Renin locus.

Flister MJ, Hoffman MJ, Reddy P, Jacob HJ, Moreno C.

Hypertension. 2013 Apr;61(4):850-6. doi: 10.1161/HYPERTENSIONAHA.111.01008. Epub 2013 Mar 4.

33.

Identification of hypertension susceptibility loci on rat chromosome 12.

Flister MJ, Prisco SZ, Sarkis AB, O'Meara CC, Hoffman M, Wendt-Andrae J, Moreno C, Lazar J, Jacob HJ.

Hypertension. 2012 Oct;60(4):942-8. doi: 10.1161/HYPERTENSIONAHA.112.198200. Epub 2012 Aug 6.

34.

New model of macrophage acquisition of the lymphatic endothelial phenotype.

Hall KL, Volk-Draper LD, Flister MJ, Ran S.

PLoS One. 2012;7(3):e31794. doi: 10.1371/journal.pone.0031794. Epub 2012 Mar 2.

35.

Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases.

Volk LD, Flister MJ, Chihade D, Desai N, Trieu V, Ran S.

Neoplasia. 2011 Apr;13(4):327-38.

36.

Characterization of Prox1 and VEGFR-3 expression and lymphatic phenotype in normal organs of mice lacking p50 subunit of NF-κB.

Flister MJ, Volk LD, Ran S.

Microcirculation. 2011 Feb;18(2):85-101. doi: 10.1111/j.1549-8719.2010.00057.x.

37.

Lymphangiogenesis and lymphatic metastasis in breast cancer.

Ran S, Volk L, Hall K, Flister MJ.

Pathophysiology. 2010 Sep;17(4):229-51. doi: 10.1016/j.pathophys.2009.11.003. Epub 2009 Dec 24.

38.

Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S.

Blood. 2010 Jan 14;115(2):418-29. doi: 10.1182/blood-2008-12-196840. Epub 2009 Nov 9.

39.
40.

Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.

Whitehurst B, Flister MJ, Bagaitkar J, Volk L, Bivens CM, Pickett B, Castro-Rivera E, Brekken RA, Gerard RD, Ran S.

Int J Cancer. 2007 Nov 15;121(10):2181-91.

Supplemental Content

Loading ...
Support Center